Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC)
Targeted therapies have improved patient survival in metastatic lung adenocarcinoma. Molecular diagnosis is a key element to identify oncogenic drivers predicting the efficacy of these agents. In stage IV patients, histopathological diagnosis is often ...
Bonekey Rep . 2014 Oct 1;3:580. doi: 10.1038/bonekey.2014.75 Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC) Cyrille B Confavreux Cyrille B Confavreux 1 Inserm UMR1033-Université de Lyon, Lyon, France 2 Rheumatology Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France Find articles by Cyrille B Confavreux 1, 2, a , Nicolas Girard Nicolas Girard 3 Respiratory Medicine, Thoracic Oncology Department, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France Find articles by Nicolas Girard 3 , Jean-Baptiste Piala
related reading
- Research advances in treatment strategies for breast cancer liver metastases: A comprehensive review - PMCpmc.ncbi.nlm.nih.gov
- Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for non-small cell lung cancer undergoing radical surgerynature.com
- In Brief: Classifications in Brief: Enneking Classification: Benign and Malignant Tumors of the Musculoskeletal System - PMCncbi.nlm.nih.gov
- Current and Emerging Approaches for Spine Tumor Treatmentpmc.ncbi.nlm.nih.gov
- Mutational interactions define novel cancer subgroupsnature.com
- Epigenetic regulation during cancer transitions across 11 tumour typesnature.com
- Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance - PMCncbi.nlm.nih.gov
- Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangementsnature.com
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanomanature.com
- Pancreatic Cancer - PMCncbi.nlm.nih.gov
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemianature.com